CN104678108A - Detecting card for bone alkaline phosphatase, hemoglobin and glutamic-pyruvic transaminase - Google Patents
Detecting card for bone alkaline phosphatase, hemoglobin and glutamic-pyruvic transaminase Download PDFInfo
- Publication number
- CN104678108A CN104678108A CN201510095141.0A CN201510095141A CN104678108A CN 104678108 A CN104678108 A CN 104678108A CN 201510095141 A CN201510095141 A CN 201510095141A CN 104678108 A CN104678108 A CN 104678108A
- Authority
- CN
- China
- Prior art keywords
- sample
- pad
- application
- zone
- filtrating area
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 title claims abstract description 17
- 108010082126 Alanine transaminase Proteins 0.000 title claims abstract description 17
- 102000002260 Alkaline Phosphatase Human genes 0.000 title abstract description 4
- 108020004774 Alkaline Phosphatase Proteins 0.000 title abstract description 4
- 102000001554 Hemoglobins Human genes 0.000 title abstract description 4
- 108010054147 Hemoglobins Proteins 0.000 title abstract description 4
- 210000000988 bone and bone Anatomy 0.000 title abstract description 3
- 238000006243 chemical reaction Methods 0.000 claims abstract description 34
- 239000000020 Nitrocellulose Substances 0.000 claims abstract description 22
- 229920001220 nitrocellulos Polymers 0.000 claims abstract description 22
- 238000001514 detection method Methods 0.000 claims description 26
- 239000002250 absorbent Substances 0.000 claims description 11
- 230000002745 absorbent Effects 0.000 claims description 10
- 239000003153 chemical reaction reagent Substances 0.000 claims description 10
- 238000012360 testing method Methods 0.000 claims description 10
- 102000004169 proteins and genes Human genes 0.000 claims description 4
- 108090000623 proteins and genes Proteins 0.000 claims description 4
- 239000012528 membrane Substances 0.000 abstract 5
- 238000001914 filtration Methods 0.000 abstract 4
- 238000010521 absorption reaction Methods 0.000 abstract 3
- 229920000915 polyvinyl chloride Polymers 0.000 abstract 3
- 239000004800 polyvinyl chloride Substances 0.000 abstract 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 3
- 238000003908 quality control method Methods 0.000 abstract 2
- 238000003745 diagnosis Methods 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000013399 early diagnosis Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 208000001132 Osteoporosis Diseases 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 208000007442 rickets Diseases 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical group [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 108010044467 Isoenzymes Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000003150 biochemical marker Substances 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000008576 chronic process Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 150000003278 haem Chemical class 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000000963 osteoblast Anatomy 0.000 description 1
- 230000001582 osteoblastic effect Effects 0.000 description 1
- 230000002188 osteogenic effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012113 quantitative test Methods 0.000 description 1
- 238000012764 semi-quantitative analysis Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
- G01N33/721—Haemoglobin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54306—Solid-phase reaction mechanisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
The invention discloses a detecting card for bone alkaline phosphatase, hemoglobin and glutamic-pyruvic transaminase. The detecting card comprises a PVC (polyvinyl chloride) bottom plate, a sample pad, a fluorescent pad, a nitrocellulose membrane, a detecting line, a quality control line, water absorption filter paper, sample feeding ports, sample adding tubes, a support, a stop piece, a sample adding zone, a reaction zone, a sample flowing pad, a bulge, a reaction film and an added sample filtering zone, wherein the sample pad, the nitrocellulose membrane, the fluorescent pad, the water absorption filter paper, the added sample filtering zone, the sample flowing pad, the bulge, the sample adding zone and the reaction zone are arranged on the PVC bottom plate; one end of the sample pad is overlapped on the fluorescent pad, the other end of the fluorescent pad is overlapped on the nitrocellulose membrane, the water absorption filter paper is overlapped at the other end of the nitrocellulose membrane, the detecting line and the quality control line are formed on the nitrocellulose membrane, the added sample filtering zone and the sample flowing pad are contacted, and the sample adding tubes are arranged above the sample pad, the added sample filtering zone and the sample adding zone. The detecting card has the advantages of simplicity, convenience and rapidness in operation and the like.
Description
Technical field
The present invention relates to a kind of NBAP, haemoglobin, glutamic-pyruvic transaminase test card, be applied to medical science external diagnosis reagent field.
Background technology
NBAP (BALP) is a hypotype in alkaline phosphatase isoenzyme, synthesized by Gegenbaur's cell, it mainly concentrates on ossified position, NBAP is the biomacromolecule with catalytic activity of Gegenbaur's cell synthesis, its hetero-organization and organ do not synthesize BALP, for osteogenic tissue is peculiar.BALP activity is directly proportional to the osteoblastic quantity of activity, is the single-minded mark of reflection osteoblast activity and quantity.So its active height is direct, special, the formation that reflects bone delicately with absorb multidate information, be one and there is tissue specificity, cover the full course of disease, not by the biochemical marker that other conditions affect.Children's's NBAP is mainly used in the specificity reference index of Rickets early diagnosis and subclinical discriminating in recent years, adult's NBAP detects for pregnant and lying-in women, pregnant and lying-in women can be instructed in time to replenish the calcium safely and effectively and osteoporosis examination in postpartum.For the elderly, can examination osteoporosis.Rachitic pathogenic process is a chronic process, and primary clinical manifestation does not have specificity, until treating when there is obvious skeleton change.The best period for the treatment of will be missed.Adverse effect is caused to upgrowth and development of children, therefore, in clinical position, needs an index to weigh treatment level.Prevent insufficient therapy or excessive.Simple dependence sings and symptoms easily causes mistaken diagnosis and fails to pinpoint a disease in diagnosis.Blood calcium in the past, phosphorus, whole blood alkaline phosphatase and x-ray detection sensitivity are low, poor specificity.Shall not be applied to early diagnosis.25 (OH) D3 is the reliable index of vitD nutrition condition in internationally recognized antimer. can be used as the index of early diagnosis.This laboratory operating procedures is loaded down with trivial details.Be not suitable for carrying out in primary care health institution.The detection of children's's NBAP, there is the advantages such as easy, quick, special, responsive, the clinical practice of this reagent provides the diagnosis basis of science to early detection rickets, very large clinical meaning is had to guiding clinical treatment, current detection NBAP product is semi-quantitative analysis, and testing result cannot quantitative test.
Haemoglobin (Hb) is erythrocytic principal ingredient, haemoglobin is made up of four chains, article two, α chain and two β chains, each chain has a ring-like heme comprising an iron atom, haemoglobin is a kind of protein being responsible for delivery oxygen in human body, haemoglobin is the most important index diagnosing severity of anemia clinically, also be the hemopathic important indicators of auxiliary diagnosis other types simultaneously, at present, clinical labororatory's many employings Automatic Blood Cell Analyzer Measuring hemoglobin, there is sense cycle long, need a large amount of reagent, carry inconvenience, be not suitable for the quick detection of haemoglobin individual event object quick test beyond laboratory and blood donor's haemoglobin in enormous quantities.Germany produces DE202 portable Hemoglobin Meter, and also to there is microplate volume comparatively large, not easily location and the higher deficiency of use cost.
Glutamic-pyruvic transaminase (ALT) is a kind of non-plasma-specific enzyme, and the dimer be made up of two identical polypeptied chain subunits, molecular weight is 110 kD.Glutamic-pyruvic transaminase is free to be present in cytoplasm, especially the abundantest in liver cell.Inside and outside liver cell, ion difference changes, cell membrane swelling, when the increase of cell hole or meronecrosis, glutamic-pyruvic transaminase can be released in blood in cell, clear or the blood plasma glutamic-pyruvic transaminase of hyperamization significantly increases, therefore glutamic-pyruvic transaminase is the most responsive a kind of Testing index of hepatic disorder by world health organisation recommendations, and current clinical detection glutamic-pyruvic transaminase mainly uses the method for the liquid reagent of Biochemical Analyzer, and the method is consuming time, complicated operation, need than relatively large instrument.
Summary of the invention
For solving the defect of prior art, the invention discloses a kind of energy simultaneous quantitative and detecting NBAP, haemoglobin, glutamic-pyruvic transaminase content, NBAP simple and efficient to handle, haemoglobin, glutamic-pyruvic transaminase test card.
The invention discloses a kind of NBAP, haemoglobin, glutamic-pyruvic transaminase test card, comprising: PVC base plate, sample pad, fluorescence pad, nitrocellulose filter, detection line, nature controlling line, absorbent filter, sample inlet port, application of sample pipe, support, catch, sample application zone, reaction zone, sample flow pad, projection, reaction film, application of sample filtrating area, described PVC base plate is provided with sample pad, nitrocellulose filter, fluorescence pad, absorbent filter, application of sample filtrating area, sample flow pad, projection, sample application zone and reaction zone, described sample pad one end is overlapped on fluorescence pad, the described fluorescence pad other end is overlapped on nitrocellulose filter, described absorbent filter is overlapped on the nitrocellulose filter other end, described sample pad is provided with application of sample pipe, described detection line and nature controlling line are located on nitrocellulose filter, described detection line and nature controlling line are parallel to each other, and detection line is near fluorescence pad end, nature controlling line is away from fluorescence pad end, described detection line and nature controlling line are all coated with protein antibodies, described application of sample filtrating area contacts with sample flow pad, described projection is provided with reaction film, described reaction film is positioned at the top of sample flow pad, described sample application zone is communicated with reaction zone, described reaction zone is provided with blow vent, reaction reagent and the molten reagent of born of the same parents is provided with in described reaction zone, described sample pad, application of sample filtrating area, the top of sample application zone is provided with application of sample pipe, the top ports place of described application of sample pipe is provided with catch, the bottom of the application of sample pipe above described sample pad contacted with sample pad, contact with application of sample filtrating area bottom application of sample pipe above described application of sample filtrating area, the bottom of the application of sample pipe above described sample application zone contacts with sample application zone, the application of sample pipe above described sample pad, application of sample pipe above application of sample filtrating area and the application of sample Guan Jun above sample application zone by support installing on PVC base plate.
Compared with prior art beneficial effect of the present invention is: by above-mentioned setting, the detection of NBAP can be carried out by sample pad, fluorescence pad, nitrocellulose filter, absorbent filter, the detection of glutamic-pyruvic transaminase can be carried out by application of sample filtrating area, sample flow pad and reaction film, the detection of haemoglobin can be carried out by sample application zone and reaction zone, and by the design of application of sample pipe, can operating personnel pass through to application of sample pipe application of sample complete operation, thus the situation that prevents from being scattered occurs, ultimate guarantee Detection results.
Accompanying drawing explanation
Fig. 1 is the structural representation of a kind of NBAP of the present invention, haemoglobin, glutamic-pyruvic transaminase test card.
Wherein: 1-PVC base plate; 2-sample pad; 3-fluorescence pad; 4-nitrocellulose filter; 5-detection line; 6-nature controlling line; 7-absorbent filter; 8-sample inlet port; 9-application of sample pipe; 10-support; 11-catch; 12-sample application zone; 13-reaction zone; 14-sample flow pad; 15-projection; 16-reaction film; 17-application of sample filtrating area.
Embodiment
As shown in Figure 1, the invention discloses a kind of NBAP, haemoglobin, glutamic-pyruvic transaminase test card, comprising: PVC base plate 1, sample pad 2, fluorescence pad 3, nitrocellulose filter 4, detection line 5, nature controlling line 6, absorbent filter 7, sample inlet port 8, application of sample pipe 9, support 10, catch 11, sample application zone 12, reaction zone 13, sample flow pad 14, projection 15, reaction film 16, application of sample filtrating area 17, described PVC base plate 1 is provided with sample pad 2, nitrocellulose filter 4, fluorescence pad 3, absorbent filter 7, application of sample filtrating area 17, sample flow pad 14, projection 15, sample application zone 12 and reaction zone 13, described sample pad 2 one end is overlapped on fluorescence pad 3, described fluorescence pad 3 other end is overlapped on nitrocellulose filter 4, described absorbent filter 7 is overlapped on nitrocellulose filter 4 other end, described sample pad 2 is provided with application of sample pipe 9, described detection line 5 and nature controlling line 6 are located on nitrocellulose filter 4, described detection line 5 and nature controlling line 6 are parallel to each other, and detection line 5 is near fluorescence pad 3 end, nature controlling line 6 is away from fluorescence pad 3 end, described detection line 5 and nature controlling line 6 are all coated with protein antibodies, described application of sample filtrating area 17 contacts with sample flow pad 14, described projection 15 is provided with reaction film 16, described reaction film 16 is positioned at the top of sample flow pad 14, described sample application zone 12 is communicated with reaction zone 13, described reaction zone 13 is provided with blow vent, reaction reagent and the molten reagent of born of the same parents is provided with in described reaction zone 13, described sample pad 2, application of sample filtrating area 17, the top of sample application zone 12 is provided with application of sample pipe 9, the top ports place of described application of sample pipe 9 is provided with catch 11, the bottom of the application of sample pipe 9 above described sample pad 2 contacted with sample pad 2, contact with application of sample filtrating area 17 bottom application of sample pipe 9 above described application of sample filtrating area 17, the bottom of the application of sample pipe 9 above described sample application zone 12 contacts with sample application zone 12, the application of sample pipe 9 above described sample pad 2, application of sample pipe 9 above application of sample filtrating area 17 and the application of sample pipe 9 above sample application zone 12 are all arranged on PVC base plate 1 by support 10.
Above embodiment only in order to the present invention is described and and unrestricted technical scheme described in the invention; Therefore, although this instructions with reference to each above-mentioned embodiment to present invention has been detailed description, those of ordinary skill in the art should be appreciated that and still can modify to the present invention or equivalent to replace; And all do not depart from technical scheme and the improvement thereof of the spirit and scope of the present invention, it all should be encompassed in right of the present invention.
Claims (1)
1. a NBAP, haemoglobin, glutamic-pyruvic transaminase test card, comprising: PVC base plate, sample pad, fluorescence pad, nitrocellulose filter, detection line, nature controlling line, absorbent filter, sample inlet port, application of sample pipe, support, catch, sample application zone, reaction zone, sample flow pad, projection, reaction film, application of sample filtrating area, is characterized in that: described PVC base plate is provided with sample pad, nitrocellulose filter, fluorescence pad, absorbent filter, application of sample filtrating area, sample flow pad, projection, sample application zone and reaction zone, described sample pad one end is overlapped on fluorescence pad, the described fluorescence pad other end is overlapped on nitrocellulose filter, described absorbent filter is overlapped on the nitrocellulose filter other end, described sample pad is provided with application of sample pipe, described detection line and nature controlling line are located on nitrocellulose filter, described detection line and nature controlling line are parallel to each other, and detection line is near fluorescence pad end, nature controlling line is away from fluorescence pad end, described detection line and nature controlling line are all coated with protein antibodies, described application of sample filtrating area contacts with sample flow pad, described projection is provided with reaction film, described reaction film is positioned at the top of sample flow pad, described sample application zone is communicated with reaction zone, described reaction zone is provided with blow vent, reaction reagent and the molten reagent of born of the same parents is provided with in described reaction zone, described sample pad, application of sample filtrating area, the top of sample application zone is provided with application of sample pipe, the top ports place of described application of sample pipe is provided with catch, the bottom of the application of sample pipe above described sample pad contacted with sample pad, contact with application of sample filtrating area bottom application of sample pipe above described application of sample filtrating area, the bottom of the application of sample pipe above described sample application zone contacts with sample application zone, the application of sample pipe above described sample pad, application of sample pipe above application of sample filtrating area and the application of sample Guan Jun above sample application zone by support installing on PVC base plate.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510095141.0A CN104678108A (en) | 2015-03-04 | 2015-03-04 | Detecting card for bone alkaline phosphatase, hemoglobin and glutamic-pyruvic transaminase |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510095141.0A CN104678108A (en) | 2015-03-04 | 2015-03-04 | Detecting card for bone alkaline phosphatase, hemoglobin and glutamic-pyruvic transaminase |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104678108A true CN104678108A (en) | 2015-06-03 |
Family
ID=53313452
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510095141.0A Pending CN104678108A (en) | 2015-03-04 | 2015-03-04 | Detecting card for bone alkaline phosphatase, hemoglobin and glutamic-pyruvic transaminase |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104678108A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106353261A (en) * | 2016-08-31 | 2017-01-25 | 长沙励思生物技术有限公司 | Bone alkaline phosphatase analyzer |
| CN109085348A (en) * | 2017-08-21 | 2018-12-25 | 上海荒岛科技有限公司 | A kind of method for analyzing body fluid |
| CN111197071A (en) * | 2020-01-10 | 2020-05-26 | 杭州联晟生物科技有限公司 | Test card for detecting glutamic-pyruvic transaminase by photochemical method and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103412115A (en) * | 2013-07-19 | 2013-11-27 | 郭宗明 | Glutamic-pyruvic transaminase and ferrohemoglobin detection card |
| CN103412123A (en) * | 2013-09-03 | 2013-11-27 | 天津朗赛生物科技有限公司 | Bone alkaline phosphatase test strip and preparation method thereof |
| CN203858249U (en) * | 2014-05-26 | 2014-10-01 | 安徽惠邦生物工程股份有限公司 | Novel detection test strip |
-
2015
- 2015-03-04 CN CN201510095141.0A patent/CN104678108A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103412115A (en) * | 2013-07-19 | 2013-11-27 | 郭宗明 | Glutamic-pyruvic transaminase and ferrohemoglobin detection card |
| CN103412123A (en) * | 2013-09-03 | 2013-11-27 | 天津朗赛生物科技有限公司 | Bone alkaline phosphatase test strip and preparation method thereof |
| CN203858249U (en) * | 2014-05-26 | 2014-10-01 | 安徽惠邦生物工程股份有限公司 | Novel detection test strip |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106353261A (en) * | 2016-08-31 | 2017-01-25 | 长沙励思生物技术有限公司 | Bone alkaline phosphatase analyzer |
| CN109085348A (en) * | 2017-08-21 | 2018-12-25 | 上海荒岛科技有限公司 | A kind of method for analyzing body fluid |
| CN109085348B (en) * | 2017-08-21 | 2019-07-23 | 上海荒岛科技有限公司 | A kind of method for analyzing body fluid |
| CN111197071A (en) * | 2020-01-10 | 2020-05-26 | 杭州联晟生物科技有限公司 | Test card for detecting glutamic-pyruvic transaminase by photochemical method and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lala et al. | Liver function tests | |
| Alpert et al. | α-Fetoprotein in human hepatoma: improved detection in serum, and quantitative studies using a new sensitive technique | |
| Kolesnikova et al. | Integral indicator of oxidative stress in human blood | |
| JP2015121559A (en) | Testing system for determining hypoxia induced cellular damage | |
| RU2007132921A (en) | METHOD FOR DIAGNOSTIC OF HEPATIC STEATOSIS BY BIOCHEMICAL MARKERS | |
| CN105021596A (en) | Concentration gradient based dry chemical test strip with multiple layers of films | |
| Jiang et al. | Urinary concentrations of phthalate metabolites associated with changes in clinical hemostatic and hematologic parameters in pregnant women | |
| JPH06510210A (en) | Blood loss monitoring method and device | |
| CN104678108A (en) | Detecting card for bone alkaline phosphatase, hemoglobin and glutamic-pyruvic transaminase | |
| Zhang et al. | The significance of combined detection of CysC, urinary mAlb and β2-MG in diagnosis of the early renal injury in pregnancy-induced hypertension syndrome | |
| CN106353511A (en) | Urinary microalbumin (U-mALb)/urinary creatinine (U-Cr) integrated assay bigeminy strip and preparation method thereof | |
| Osborne et al. | Carbon monoxide as a clinical marker of hemolysis | |
| CN108318698A (en) | A kind of fecal occult blood latex enhancing Immunoturbidimetric kit | |
| CN108548928A (en) | A kind of kit and detection method of quick detection spermatozoon activity | |
| CN104535768B (en) | A kind of microdose urine protein detecting device | |
| CN106093387A (en) | A kind of test kit measuring NBAP | |
| Delvin et al. | Trace elements: functions and assessment of status through laboratory testing | |
| Wu et al. | Pseudohypophosphatemia in a patient with multiple myeloma | |
| CN207472899U (en) | A kind of kit for quantitatively detecting NGAL in urine or blood | |
| Dutta et al. | Anthropometric markers with specific cut-offs can predict anemia occurrence among Malaysian young adults | |
| Goonewardene et al. | Iron stores and its correlation to haemoglobin levels in pregnant women attending | |
| RU2115118C1 (en) | Method of assay of iron prelatent deficiency in children | |
| CN113514604A (en) | Method for measuring total chlorine content in sodium citrate-containing compound preparation | |
| CN113063944A (en) | Application of serum GSDME in diagnosis, curative effect monitoring and prognosis evaluation of B lymphocyte leukemia | |
| CN205898692U (en) | Lack kit that albumin was decoratied to blood among quick detect blood |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150603 |